[Media Releases] [BIO Korea 2011]Interview of CEO of LegoChem

Title: BIO Korea 2011– Interview of CEO of LegoChem

Publication: BIO Korea 2011

Date: 01 October 2011

Summary

• Interview clip of Yong Zu Kim, CEO of LegoChem in BioKorea 2011

   

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).